Toronto-based Cybin is set to acquire London-based Small Pharma in an all-share transaction, according to an announcement by Cybin this morning. Small Pharma shareholders will receive 0.2409 Cybin shares for each share of Small Pharma, implying approximately $0.10 per Small Pharma share: a price the company’s stock hasn’t seen since last winter. When all is said and done…
